Apple and Eli Lilly have partnered with healthtech start-up Evidation for an early-stage, 12-week study assessing whether Apple's technology could help detect signs of cognitive decline. Data was collected via iPhone, Apple Watch, iPad and Apple-owned Beddit's sleep monitoring device, with initial results suggesting the devices could identify behaviours including increased reliance on helper apps. The study, which is being conducted in collaboration with Stanford University, will be published later this year by the journal Nature Communications.
Apple and Eli Lilly have partnered with healthtech start-up Evidation for an early-stage, 12-week study assessing whether Apple's technology could help detect signs of cognitive decline. Data was collected via iPhone, Apple Watch, iPad and Apple-owned Beddit's sleep monitoring device, with initial results suggesting the devices could identify behaviours including increased reliance on helper apps. Dementia affects approximately 47 million people worldwide and costs $1tn, according to the World Health Organization.